Related references
Note: Only part of the references are listed.Understanding the Uptake of Nanomedicines at Different Stages of Brain Cancer Using a Modular Nanocarrier Platform and Precision Bispecific Antibodies
Zachary H. Houston et al.
ACS CENTRAL SCIENCE (2020)
Hyperbranched Poly(2-oxazoline)s and Poly(ethylene glycol): A Structure-Activity Comparison of Biodistribution
James Humphries et al.
BIOMACROMOLECULES (2020)
Global, regional, and national burden of brain and other CNS cancer, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Anoop P. Patel et al.
LANCET NEUROLOGY (2019)
Selective interstitial doxorubicin for recurrent glioblastoma
Valerii Matcovschii et al.
CLINICAL CASE REPORTS (2019)
Hypoxic glioblastoma release exosomal VEGF-A induce the permeability of blood-brain barrier
Chen Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment
Lakshmi Pallavi Ganipineni et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Sustained Delivery of Doxorubicin via Acetalated Dextran Scaffold Prevents Glioblastoma Recurrence after Surgical Resection
Elizabeth Graham-Gurysh et al.
MOLECULAR PHARMACEUTICS (2018)
Designed multifunctional polymeric nanomedicines: long-term biodistribution and tumour accumulation of aptamer-targeted nanomaterials
N. L. Fletcher et al.
CHEMICAL COMMUNICATIONS (2018)
Minimum information reporting in bio-nano experimental literature
Matthew Faria et al.
NATURE NANOTECHNOLOGY (2018)
Indications and Efficacy of Gamma Knife Stereotactic Radiosurgery for Recurrent Glioblastoma: 2 Decades of Institutional Experience
Brandon S. Imber et al.
NEUROSURGERY (2017)
Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics
Yongmei Zhao et al.
MOLECULAR PHARMACEUTICS (2017)
Effects of Surface Charge of Hyperbranched Polymers on Cytotoxicity, Dynamic Cellular Uptake and Localization, Hemotoxicity, and Pharmacokinetics in Mice
Liyu Chen et al.
MOLECULAR PHARMACEUTICS (2017)
Bridging Bio-Nano Science and Cancer Nanomedicine
Mattias Bjornmalm et al.
ACS NANO (2017)
Localised delivery of doxorubicin to prostate cancer cells through a PSMA-targeted hyperbranched polymer theranostic
Amanda K. Pearce et al.
BIOMATERIALS (2017)
Targeting Nanomedicines to Prostate Cancer: Evaluation of Specificity of Ligands to Two Different Receptors In Vivo
Amanda K. Pearce et al.
PHARMACEUTICAL RESEARCH (2016)
Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies
Christopher B. Howard et al.
ADVANCED HEALTHCARE MATERIALS (2016)
Glioblastoma: Overview of Disease and Treatment
Mary Elizabeth Davis
CLINICAL JOURNAL OF ONCOLOGY NURSING (2016)
Evaluation of Polymeric Nanomedicines Targeted to PSMA: Effect of Ligand on Targeting Efficiency
Adrian V. Fuchs et al.
BIOMACROMOLECULES (2015)
Capturing the Molecular and Biological Diversity of High-Grade Astrocytoma in Genetically Engineered Mouse Models
Lionel M.L. Chow et al.
Oncotarget (2015)
EPHRINA2 RECEPTOR IN HUMAN GLIOBLASTOMA CANCER STEM CELLS AND IDENTIFICATION OF NEW, PUTATIVE THERAPEUTIC TARGETS
Angelo Luigi Vescovi et al.
NEURO-ONCOLOGY (2014)
Improved survival time trends for glioblastoma using the SEER 17 population-based registries
Matthew Koshy et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Cooperativity within and among Pten, p53, and Rb Pathways Induces High-Grade Astrocytoma in Adult Brain
Lionel M. L. Chow et al.
CANCER CELL (2011)
Efficient Chemotherapy of Rat Glioblastoma Using Doxorubicin-Loaded PLGA Nanoparticles with Different Stabilizers
Stefanie Wohlfart et al.
PLOS ONE (2011)
Doxorubicin pathways: pharmacodynamics and adverse effects
Caroline F. Thorn et al.
PHARMACOGENETICS AND GENOMICS (2011)
Genetics of Glioblastoma: A Window into Its Imaging and Histopathologic Variability
Clifford J. Belden et al.
RADIOGRAPHICS (2011)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Peritumoral edema on MRI at initial diagnosis: an independent prognostic factor for glioblastoma?
K. Schoenegger et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
Selective left ventricular adriamycin-induced cardiomyopathy in the pig
Stefan Christiansen et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
EphA2 as a novel molecular marker and target in glioblastoma multiforme
J Wykosky et al.
MOLECULAR CANCER RESEARCH (2005)
Polymeric micellar pH-sensitive drug delivery system for doxorubicin
M Hruby et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles
SCJ Steiniger et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Doxorubicin-induced cardiac mitochondrionopathy
KB Wallace
PHARMACOLOGY & TOXICOLOGY (2003)
Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs
F Ciardiello et al.
EUROPEAN JOURNAL OF CANCER (2003)
Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers
ED Hugger et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)